Market Place
Sourcing Support
Shunned by insurers, digital therapeutics startups look for ways to get paid
02 Jan 2024 //
ENDPTS
Nox Health Closes Acquisition of Somryst, the Only FDA Pear Therapeutics
20 Jun 2023 //
GLOBENEWSWIRE
Pear Therapeutics apps sell for $6M in post-bankruptcy auction
19 May 2023 //
FIERCE BIOTECH
Digital therapeutics maker Pear files for bankruptcy, lays off 170 staffers
11 Apr 2023 //
ENDPTS
Pear Tx files for bankruptcy, will seek to sell assets
07 Apr 2023 //
PHARMAPHORUM
Pear Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process
07 Apr 2023 //
BUSINESSWIRE
Pear Therapeutics exploring a sale amid hemorrhaging costs
17 Mar 2023 //
FIERCE BIOTECH
Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference
27 Feb 2023 //
BUSINESSWIRE
Pear Therapeutics and BrightView Health Expand Pilot Program
26 Jan 2023 //
BUSINESSWIRE
Pear Announces Inclusion of reSET & reSET-O on Medicaid Preferred Drug List
18 Jan 2023 //
BUSINESSWIRE
Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis
10 Jan 2023 //
BUSINESSWIRE
Pear and Spero to Expand Access to Prescription Digital Therapeutics for People
04 Jan 2023 //
BUSINESSWIRE
Pear Therapeutics Presents Data Assessing Engagement & Abstinence in Patients
15 Dec 2022 //
BUSINESSWIRE
Pear Therapeutics trims workforce by another 22%
16 Nov 2022 //
FIERCEBIOTECH
Pear Therapeutics undergoes another round of layoffs, cutting 22% of staff
15 Nov 2022 //
MEDTECHDIVE
Pear Therapeutics Reports Third Quarter 2022 Results
14 Nov 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in the BTIG Digital Health Forum
10 Nov 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in the Credit Suisse 31st Conference
01 Nov 2022 //
BUSINESSWIRE
Pear Therapeutics to Issue Third Quarter 2022 Financial Results
31 Oct 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium
13 Sep 2022 //
BUSINESSWIRE
Pear to Participate in the Morgan Stanley Annual Global Healthcare Conference
07 Sep 2022 //
BUSINESSWIRE
SCDC & Pear Team up to Support Inmates in Recovery from Substance Use Disorders
01 Sep 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference
31 Aug 2022 //
BUSINESSWIRE
Pear Therapeutics trims workforce, forecast as state contracts move slower
12 Aug 2022 //
MEDTECHDIVE
Pear Therapeutics touts Q2 growth while scaling back full-year goalschopping 9%
12 Aug 2022 //
ENDPTS
Pear Therapeutics Announces Publication of Real-World Data
10 Aug 2022 //
BUSINESS WIRE
Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA
08 Aug 2022 //
BUSINESS WIRE
Pear and Cove Behavioral Health to Provide Patients Access to PDT
03 Aug 2022 //
BUSINESSWIRE
Pear Therapeutics to be Added to Russell US Index Series
02 Aug 2022 //
BUSINESSWIRE
Pear Tx to Issue Second Quarter 2022 Financial Results
28 Jul 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in the Cowen 7th Annual FutureHealth Conference
16 Jun 2022 //
BUSINESSWIRE
Pear Tx Announces 12-Month Analysis Showing Reduction in Resource Utilization
14 Jun 2022 //
BUSINESSWIRE
Pear Therapeutics Announces New Analysis Showing Use of reSET at Six Months
06 Jun 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in the Jefferies Healthcare Conference
02 Jun 2022 //
BUSINESSWIRE
Pear Announces Health Equity Data Showing Similar Engagement with reSET-O
24 May 2022 //
BUSINESSWIRE
Pear Therapeutics Announces the Inclusion of QuickMD
12 May 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in the 17th Annual Needham Conference
11 May 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in the Bank of America 2022 Conference
03 May 2022 //
BUSINESSWIRE
Pear Therapeutics to Issue First Quarter 2022 Financial Results
02 May 2022 //
BUSINESSWIRE
Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit
18 Apr 2022 //
BUSINESSWIRE
Pear Tx Receives STeP Designation from FDA to Treat Acute and Chronic Pain
13 Apr 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in Upcoming Investor Conferences
05 Apr 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in Upcoming Investor Event
31 Mar 2022 //
BUSINESSWIRE
Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
28 Mar 2022 //
BUSINESSWIRE
Pear Tx says Data from Two Studies Evaluating Prescription Digital Tx
15 Mar 2022 //
BUSINESSWIRE
Pear Tx to Host Q4 and Full Year 2021 Earnings Conference Call
14 Mar 2022 //
BUSINESSWIRE
Pear Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference
02 Mar 2022 //
BUSINESSWIRE
Pear Tx Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy
24 Feb 2022 //
BUSINESSWIRE
Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish
15 Feb 2022 //
BUSINESSWIRE
Pear Therapeutics Announces Operational Performance Metrics
18 Jan 2022 //
BUSINESSWIRE
Pear Therapeutics and Thimble Point Announce Closing of Business Combination
03 Dec 2021 //
BUSINESSWIRE
Pear nabs FDA breakthrough tag for alcoholism digital therapy
23 Nov 2021 //
BIOSPACE
Pear Provides 2021 Business Update, Reaffirms Full Year 2021 Revenue Guidance
15 Nov 2021 //
BUSINESSWIRE
Inclusion of reSET and reSET-O on the November 2021 MassHealth Lists
09 Nov 2021 //
BUSINESSWIRE
Pear, Thimble Point Announce Effectiveness of S-4 Registration Statement
27 Oct 2021 //
BUSINESSWIRE
Pear Therapeutics Launches Pear Prescription Digital Therapeutics Digest
19 Oct 2021 //
BUSINESSWIRE
Pear Therapeutics Announces First State Medicaid Program Decision
13 Oct 2021 //
BIOSPACE
Pear Therapeutics to Expand IP Portfolio for Prescription Digital Therapeutics
05 Oct 2021 //
BIOSPACE
Pear Therapeutics Announces Publication of Cost-Utility Data
01 Sep 2021 //
BUSINESSWIRE
Pear Therapeutics Announces Availability for its Commercial products at OptumRx
10 Aug 2021 //
BUSINESSWIRE
